1. Stocks
  2. Coherus Biosciences Inc
  3. Swot
swot-logo

Coherus Biosciences Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Coherus Biosciences Inc has 20 Strengths, 6 Weaknesses, 1 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Rising Momentum: Momentum Score Weekly Gainers

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock gained more than 20% in one month

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

Biggest Price Gainers from Open

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Quarter Change % less than Industry

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Declining Net Cash Flow : Companies not able to generate net cash

Declining profits every quarter for the past 2 quarters

Declining Revenue every quarter for the past 2 quarters

Institutions increasing their shareholding

Stocks rising sharply on very low month volumes

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks